Rising Prevalence Of Dermatological Problems Is Expected to Propel the Growth of The Global Catenin Beta Market.

The global catenin beta market is anticipated to grow at a considerable CAGR of around  5 % during the forecast years. Also known as beta-catenin 1, catenin beta is a protein encoded by CTNNB1 in humans. It has various functions including regulation and coordination of cells, cell adhesion, and gene transcription. The major factor driving the growth of the global catenin market is its application in the rising prevalence of dermatological problems including vitiligo. Vitiligo is a disorder in which skin loses its pigment cells causing discolored patches in various body parts. For instance, According to the Global Vitiligo Foundation, 1% of the population is affected with vitiligo with around 70 million vitiligo patients across the globe. Around 20 to 35% of vitiligo patients are children Moreover, through the availability of ?-catenin, WNT signaling regulates E-cadherin important adhesion molecule for melanocytes.

Browse the full report description of “Global Catenin Beta Market Size, Share & Trend Analysis Report by Type (BBI-801, Exisulind, M-101, and Nefopam Hydrochloride (HCL)), By Application (Dermatology, Oncology, and Genetic Disorder), Forecast (202-2028)” at https://www.omrglobal.com/industry-reports/transdermal-patches-market

The catenin beta signaling pathway has exerted antioxidant activity, which includes the promotion of GSK3? inactivation, increased ?-catenin nuclear translocation, and activation of the downstream Nrf2/ARE pathway. As per the study published on Dovepress in September 2021, the catenin beta pathway is found to play an essential role in pigmentation. The study also describes that catenin beta pathways can be an important breakthrough in the treatment of vitiligo. Thus, the increasing number of patients with vitiligo and the application of catenin beta in various medical fields are expected to propel the growth of the global catenin beta market.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Application

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- AstraZeneca, GlaxoSmithKline plc., Merck Group, Novartis International AG, Sumitomo Dainippon Pharma Oncology, Inc., and Others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Catenin Beta Market Report Segment

By Type

• BBI-801
• Exisulind
• M-101
• Nefopam Hydrochloride (HCL)

By Application

• Dermatology
• Oncology
• Genetic Disorder

Global Catenin Beta Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea

Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/catenin-beta-market